EUVIMEDEUVIMED entdecken
Crossref

ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer

Rachel Cordeiro, Saba Khan, Heena Tajir, Afsha Bagwan, Mohd Anas Shaikh, Ashish Gupta

German Journal of Pharmaceuticals and Biomaterials · 2022

DOI: 10.5530/gjpb.2022.3.12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift German Journal of Pharmaceuticals and Biomaterials, 2022. Verfasst von Rachel Cordeiro und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cordeiro, R., Khan, S., Tajir, H., Bagwan, A., Shaikh, M. A., & Gupta, A. (2022). ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer. German Journal of Pharmaceuticals and Biomaterials. https://doi.org/10.5530/gjpb.2022.3.12

Vancouver

Cordeiro R, Khan S, Tajir H, Bagwan A, Shaikh MA, Gupta A. ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer. German Journal of Pharmaceuticals and Biomaterials. 2022. doi:10.5530/gjpb.2022.3.12

BibTeX
@article{Cordeiro2022,
  author = {Cordeiro, Rachel and Khan, Saba and Tajir, Heena and Bagwan, Afsha and Shaikh, Mohd Anas and Gupta, Ashish},
  title = {ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer},
  journal = {German Journal of Pharmaceuticals and Biomaterials},
  year = {2022},
  doi = {10.5530/gjpb.2022.3.12}
}
Kostenlos starten →